The U.S. Food and Drug Administration has approved Aletta, a robotic device designed to automate blood draws in outpatient settings. This device uses near-infrared light and Doppler ultrasound to locate veins and then performs the entire blood draw process, from tourniquet application to bandaging. While a trained phlebotomist must initiate and supervise the procedure, one person can monitor up to three Aletta robots simultaneously, potentially alleviating shortages of trained phlebotomists. AI
IMPACT This robotic device could streamline medical procedures and address phlebotomist shortages.
RANK_REASON FDA approval of a medical device that automates a common procedure.
- Aletta
- Center for Devices and Radiological Health
- Michelle Tarver
- United States Food and Drug Administration
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
